AHSC seminar June 2018: New insights into tackling and treating cardiovascular disease
Cardiovascular disease accounts for more than a quarter of deaths in the UK.
Scientists at Imperial College London and clinicians from Imperial College Healthcare NHS Trust are working together to highlight the causes of cardiovascular disease and open new avenues for prevention and treatment.
At the next event in the Imperial College Academic Health Science Centre (AHSC) series, on 20 June, an expert from Imperial College Healthcare NHS Trust will pair up with an academic from Imperial College London to talk about their latest work in understanding and treating cardiovascular disease.
Professor Peter Weinberg from the department of bioengineering at the College will talk about his work on using experimental and computer models to understand why atherosclerosis develops only in some parts of the arterial system. Atherosclerosis is the disease underlying most heart attacks and strokes and it is characterised by lesions in the arteries made of fats, collagen and cells.
Dr Rasha Al-Lamee, interventional cardiology consultant at the Trust, will outline the findings of the ORBITA trial which looked at the impact of using heart stents to treat patients with stable angina.
A light lunch will be provided after the presentations.
To find out more and book your place, visit the Eventbrite page for the seminar.